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Abstract 
The essentiality of chromium in humans is well documented. Trivalent chromium, main 
chemistry form found in foods, is essential for maintaining normal glucose metabolism. 
Because of analytical difficulties, several literature reports of chromium content of foods, 
especially for the lower levels, show large variability and they should be interpreted with 
caution for a valid interpretation of reliable results. A Zeeman background correction 
transversely-heated graphite furnace atomic absorption spectrometry was used to 
determine the chromium content of 104 different infant formulae (cow’s milk and soy 
protein based) marked in Spain following an acid attack sample preparation procedure in a 
closed, pressurized and microwave digestion unit. 
Mean and range chromium values, regarding types and main protein-based infant formulae 
are presented. Additionally, the influence of the type of container used, the impact of 
industrial process from different manufacturers and the physical state (powder and liquid 
formulae) on chromium levels is also discussed. In general, the infant formulae contain a 
higher chromium concentration than that found in human milk (reference range: 0.20 – 
8.18 g l-1), particularly in case of hypoallergenic (18.16 ± 7.89 g l-1), lactose-free (11.37 
± 3.07 g l-1), preterm (11.48 ± 3.15 g l-1) and soya (10.43 ± 4.05 g l-1) formulae. The 
maximum theoretical estimated intake of infant fed on studied formulae was lower than the 
upper limit safety for trivalent chromium of 1 mg kg-1 (14 g Kg-1 b.w. day-1) 
recommended by the experts of Council for Responsible Nutrition (CRN ULS, 2004), 
amounting to about 10 %, 15-18 % and 26 % for standard (adapted and follow-up) and 
toddler; soya, lactose-free and preterm; and hypoallergenic formulae, respectively. 
Therefore, manufacturers are called for continued effort to routinely monitor chromium 
levels, mainly for specialised and preterm formulae, and at the same time, might consider 
the inclusion of labelling value for chromium at least in these complex formulations. 
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Introduction 
The essentiality of chromium in humans is well documented. Trivalent chromium, main 
chemistry form found un foods, is essential for maintaining normal glucose metabolism. 
Signs and symptoms of deficiency have been shown in infants suffering from kwashiorkor 
or protein-energy malnutrition, found improvement in impaired glucose tolerance after 
chromium supplementation (Anderson 1989). Nevertheless no literature report has 
described the response to chromium supplementation in infant fed breast milk or infant 
formula presently in use. Probably because those infants have not become obviously 
chromium deficient, being chromium intake likely adequate for pre- or term infants 
(Zlotkin 2003). 
Human milk feeding is the preferred nutritional model for infants during the first four to 
six months of life. Its composition, including micronutrients, is therefore used as a 
reference for infant formula manufacturing, due to the fact that infants fed on breast milk 
do not generally show trace element deficiencies. Upon cautious inspection of the data and 
references from literature, it is thus possible to suggest a reference chromium range of 0.20 
– 8.18 g l-1 for human milk (Table I). Moreover, the chromium concentration does not 
show significant variation (Deelstra et al. 1988) or exhibits slight rising tend (not 
significant) during the lactation period (Wappelhorst et al. 2002). 
[Insert table I about here] 
A reliable assessment of chromium intake is essential to avoid the potential risk of 
deficiency or, far from it, to notice the principal sings of adverse health and toxic effects 
for infants. In this respect, the estimation of the theoretical chromium intake by infants 
exclusively fed on infant formulae and the comparison with the recommended values of 
Adequate Intake (AI) and Tolerable Upper Intake Level (UL), seems to be advisable 
(FNB, 2001). 
International paediatric organizations found insufficient data on which to recommend a 
minimum or maximum chromium content of standard infant formulae (Raiten et al. 1998). 
It was noted that as this micronutrient is ubiquitous in nature a formula based on usual 
food ingredients does not need any chromium addition. However, the Australia New 
Zealand Food Authority agreed with no need for the addition or supplementation of 
chromium in adapted and follow-up formulas but suggests an amount of no less than 0.36 
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g 100 KJ-1, (10.0 g l-1) and no more than 2.0 g 100 KJ-1, (56.7 g l-1) for an infant 
formula product for specific dietary use, as preterm, specialised or soya formulae, listing 
the chromium sulphate as exclusive additional permitted chemistry form (ANZFA 2002, 
2005). 
Furthermore progress in the understanding of chromium nutritional chemistry has been 
frustratingly slow, hampered by serious analytical difficulties encountered in the accurate 
measurement of very low chromium concentrations in biological and food samples. 
Several literature reports of chromium content of foods, especially for the lower levels, 
show large variability and they should be analysed with caution for a valid interpretation 
of reliable results (Miller-Ihli 1996). 
Today many of analytical problems found have been overcome by the development of 
closed microwave attack and highly sensitive analytical instruments. Electrothermal 
atomization atomic absorption spectrometry provided with Zeeman background correction 
is recognized to be suitable for accurate chromium determination in food digests (Tinggi et 
al. 1997). Regardless chromium analysis at low levels is still considered a challenge to the 
technical skill of the analyst (Kubadda et al. 2003), in view of the fact that contamination 
of samples can relatively easily occur, although all kind of precautions were taken, a strict 
analytical quality assurance programme must be adopted to obtain reliable results 
(Krachler et al. 2000). 
The aim of the present survey was twofold. First, the quantification of chromium levels in 
the majority of infant formulae sold commercially in Spain is presented. Additionally, 
potential sources of exogenous (processing, manufacturing and packaging practices) and 
endogenous (raw material) origin on chromium levels is also discussed. It might be 
suggested that elevated chromium levels were the result of the process of manufacture 
such as different studies have reported about the probability that much of chromium 
associated with processing foods is exogenous chromium introduced during processing 
(Miller-Ihli 1996, Reilly 2002, 2004). The processing industry uses almost exclusively 
stainless containing 13 – 30 % chromium in its processing equipment material. Thus, 
contamination in infant formula with chromium should be expected. 
And finally, the determination of total chromium is appropriate to evaluate the essential 
chromium food composition data. In this nutritional context, the obtained information is of 
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paramount importance for the reliable assessment of daily chromium intake of infants fed 
on studied infant formulae. Therefore, the estimation of theoretical chromium intake from 
both, infant formulae and additional contribution of tap water to reconstitution of powder 
formulae; and its comparison with recommended values of Adequate Intake (AI) and 
Tolerable Upper Intake Level (UL) is advisable, since data on the potential adverse effects 
of chromium intake are not conclusive (FNB 2001) and, thus caution on fortification 
practices is requested to manufactures of infant formulae. 
Material and Methods 
Infant formula and water samples 
104 infant formulae samples of different commercial brands, included both powder (n = 
97) and ready to use (n = 7) formulae, were acquired from specialised markets and 
pharmacies in Pamplona (Spain). The infant formulae studied were either milk- (n = 97) or 
soy- (n = 7) based types. Different types of cow’s milk-based formulae were classified in: 
Preterm formula (n = 7, product specially formulated to satisfy particular needs of infants 
born prematurely or of low birth weight), Adapted formula (formula which satisfies the 
nutritional requirements of infants from the first day to 4-6 months of age; Type 1: formula 
adapted following the European Society for Paediatric Gastroenterology, Hepatology and 
Nutrition (ESPGHAN) recommendations (n = 21) (Koletzko et al. 2005) and Functional 1: 
formula adapted with special additives or new ingredients (n = 13), Follow-up formula 
(formula which constitutes the principal liquid source of nourishment in a progressively 
diversified diet for infants aged from six months of age; Type 2: formula adapted following 
the ESPGHAN recommendations (n = 20) and Functional 2: formula adapted with special 
additives or new ingredients (n = 10), Toddler formula (formula similar to Follow-up but 
specially designed for infants from 1 to 3 years age old, n = 6), Hypoallergenic formula 
(specialised formula which are normally based in hydrolysed proteins, n = 10), Lactose-
free formula (Formula designed as principal source of food for lactose intolerant infants, n 
= 10). 
Drinking water samples were collected from eighty eight sampling points, selected to be 
representatives of the Community of Navarra (Spain), according to a population census 
provided by the local office of the National Statistical Institute. A strict protocol was 
established to carry out tap water sampling. Tap water samples were collected in acid-
washed low density polyethylene containers. All samples were acidified with sub-boiling 
5 
nitric acid until approximately pH = 2, frozen and kept at – 20 ºC until required for 
analysis. 
Reagents and solutions 
All chemicals used were of highest purity available and all the material were nitric acid-
washed (5 %, v/v) for at least 6 days and given them a thorough rinse with ultrapure water. 
Standard and sample solutions were prepared with ultrapure deionised water type Milli-Q 
(resistivity 18 M . cm). Concentrated 65 % nitric acid (suprapur grade, Merck, 
Darmstadt, Germany) was additionally purified by sub-boiling distillation (Hans Kürner, 
Rossenheim, Germany). Working standard solution were prepared in subboiling nitric acid 
to match the acid concentration in digestion solutions from a stock 1000 mg l-1 standard 
solution supplied by Merck. A solution of magnesium nitrate (0.150 g Mg(NO3)2 . H2O -
suprapur Merck- were diluted in 100 ml with ultrapure water) was used as matrix chemical 
modifier. 
The Standard Reference Material 1549 – non-fat milk powder – (National Institute of 
Standards and Technology, Gaithersburg, USA) was used for validation of the 
methodology. 
Analytical procedures 
Special care was devoted to minimize the risk of adventitious contamination when 
handling. Infant formulae were opened in the clean room under flow laminar bench using 
talc-free gloves (Rotiprotect® Carl Roth, Karlsruhe, Germany). All steps of sample 
preparation procedure were carried out in a laboratory equipped for trace element analysis 
and following a strict handling rules. 
A infant formula sample amount of 0.3 – 0.5 g accurately weighted (powder formula) or 3 
ml of ready to use formula were placed into high pressure teflon digestion vessel and 
treated with 8 ml of sub-boiling nitric acid in a microwave digestion system (Ethos Plus, 
Millestone s.r.l., Sorisole, Italy). The optimised microwave digestion programme applied 
included two steps: 25-170 ºC for 10 min. and 170 ºC for 10 min., both at 1000 W, 
followed immediately by ventilation at room temperature. Digested samples were diluted 
to 10 ml in a volumetric flask with ultrapure water and finally, transferred to pre-cleaned 
polypropylene tubes. Solutions were kept stored frozen at - 20 ºC until analysis. All infant 
formula samples were digested in triplicate. 
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Chromium concentrations were determined in sample digestions by Zeeman background 
correction graphite furnace atomic absorption spectrometry (ZGF-AAS, Perkin Elmer 
Aanalyst 800, Norwalk, CT, USA), under the optimized operating conditions shown in 
table II. Transversely-heated graphite tubes with end caps supplied by Perkin Elmer were 
used. A single element hollow cathode lamp (Perkin Elmer) was operated at 25 mA. 
Samples and standards were atomised and all data were taken at 357.9 nm with a slit width 
of 0.7 nm. Argon of 99.9999 % purity at 250 ml min-1 flow was used as internal gas. 
Readings on the spectrometer were taken using the peak area mode. 
[Insert table II about here] 
Injections (10 l sample and 10 l matrix modifier) were made in triplicate. Measurements 
were accomplished by direct calibration using aqueous standards (0-10 g l-1) made up 
each day by dilution from stock standard solution with enough subboiling nitric acid to a 
final acid concentration similar to digested samples. The analytic sensitivity expressed as 
the characteristic mass was calculated to be 4.8 pg. 
Quality assurance 
An strict analytical quality control programme was employed during the study.  
Limit of detection and quantification: Blank reagent values were monitored throughout the 
survey and subtracted from the measured sample concentration to calculate the final result 
in infant formulae samples. Detection limit (LOD) in the acid digest solution was 
calculated according to the definition and criteria established by IUPAC (Xb + 3b) as the 
average of three times the standard deviation of the reagent blank, setting at 0.15 g l-1 (n 
= 6) equivalent to 0.51 g l-1 when expressed in terms of infant formula, calculated on the 
basis of the analytical sample weight (0.4 g), volume of dilution (10 mL) and the mean 
percentage of reconstitution (13.5 g of powder formula per 100 mL of water) for powder 
formulae or analytical sample (3mL) and dilution (10 mL) volume in the case of ready-to-
use formulae. In the same way,. the limit of quantification (LOQ = Xb + 10b) was set at 
0.18 g l-1 (n = 6) that corresponds to 0.62 g l-1 (expressed in terms of infant formula wet 
weight). Blank reagents in tap water analysis, consisting of ultrapure deionised water and 
reagents, were subjected to a similar sample preparation, storage and mixing with buffer 
solution, setting the LOD at 0.08 g l-1. 
Accuracy: The accuracy of the analytical chromium method was verified by analyzing the 
standard reference material SRM 1549 (non-fat milk powder), prior to the analysis of 
unknown infant formulae samples. 1g. of reference material was digested in the microwave 
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apparatus and diluted up to 10 mL with ultrapure water. The level of concentration 
determined in the acid solutions (mean ± standard deviation value: 0.240 ± 0.009 g l-1), 
close to the LOQ, provides the reliability of the analytical method. The found value (mean 
± standard deviation at 95 % confidence interval: 2.40 ± 0.06 ng g-1, n = 12) show 
acceptable good agreement with SRM chromium certified value (2.6 ± 0.7 ng g-1). 
Moreover, analytical recoveries of spiked chromium at different amounts (2, 4 and 8 ng) 
before digestion in SRM 1549 samples were satisfactory (95.5 – 104.1 %). Recovery 
assays were carried out at different weights (0.75 and 1.0 g) of SRM 1549 samples, 
obtaining similar results. This test is particularly sensitive at low concentration to reveal 
analytical errors and it could be considered as an evaluation of accuracy, complementary 
to recovery studies (Dabeka and Ihnat 1996). 
Precision: The instrumental precision estimated from six consecutive measures of the same 
infant formula (10.18 ± 0.09 g l-1) was 0.8 %. The relative standard deviation of the 
method determined in the intra-assay precision (aliquots of samples measured during the 
same assay session) for the blank reagent (14.0 %), SRM 1549 samples (3.6 %) and 
internal aqueous control (2.4 %) were comparable with those calculated for the inter-assay 
precision (aliquots of the same sample measured in different days), 21.6 %, 7.3 % and 4.8 
%, respectively. 
Quality control: An internal aqueous quality control (1.04 ± 0.02 g l-1, range = 0.93 – 
1.14, n = 36) was run concurrently with blank reagent and SRM 1549 digestion, 
throughout the course of the analysis and always previously measured to each batch of 
samples, in order to satisfy the criteria established in the quality program (lower and upper 
action limits: 0.85 and 1.15 g l-1, respectively) and to provide on – going quality control 
information. 
Statistical Analysis 
All statistical analyses were run using SPSS v.11.0 for Windows program. The 
Kolmogorov-Smirnov statistic was used to assess the normality of the data distributions. 
Different groups of infant formula samples (classified as types or predominant protein 
content) were compared through non-parametric Kruskal-Wallis and Mann-Whitney U-test 
or Wilcoxon Signed Rank test for independient or paired groups, with statistical 
significance set al p < 0.05). 
Results and Discussion 
Chromium levels in infant formula 
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Table III summarizes the chromium concentrations for each of the different types of infant 
formula studied. The results are expressed as g l-1 according to the manufacturer’s 
dilution (Adapted: 12.80 – 15.9 %, Follow-up: 12.7 – 16 %; Toddler: 14.0 – 16.0 %, 
Preterm: 14.7 – 15.9, Hypoallergenic: 12.8 – 15.2, Lactose-free: 12.6 – 14.0 %, Soya: 12.7 
– 13.5 %) instructions, owing to the fact that usually levels of trace elements in formulae 
are expressed in literature on a ready-to-use basis. 
In a first approach, the complete distribution of chromium content in studied infant 
formula shows a positive skew (skewness value 0.89) with scores clustered to the left at 
the low values and a positive kurtosis value (0.32) indicating a rather peaked distribution 
(clustered in the centre). In spite of the result of the test of normality suggests a violation 
of the assumption of normality, fact quite common in larger samples (Pallant 2003), the 
inspection of the normal probability plot (Normal Q-Q plot) and the assessment of 
normality in the different distributions of distinct types of infant formula allow the use of 
mean (± standard deviation at 95 % confidence interval) and the range as useful 
information concerning the statistical description of data. Median is also included in table 
III as informative value and, at the same time, the most representative parameter in those 
distributions with short number of samples. 
[Insert table III about here] 
Globally, considering all 104 formulae together, chromium concentration determined (9.60 
± 1.13 g l-1, range 2.06 – 46.50) is higher than that found in mature human milk. 
Chromium values in breast milk reported from other researchers exhibit large differences. 
Mainly, older data tended to be high due to the lack of precautions to avoid contamination 
of the sample and the inadequate analytical quality assurance scheme adopted to obtain 
reliable results. 
In this respect, as might be expected due to analytical difficulties, a wide variability in 
infant formula chromium content reported in literature is highlighted in table IV. 
Determined chromium values are in good agreement with the findings of most authors in 
formulae from different countries. However, values reported in some surveys (Biego et al. 
1998, MAFF 1999) are considerably higher probably due to the limited number of samples 
or insufficient control of contamination in sample handling. 
[Insert table IV about here] 
Undoubtedly, the differences in the chromium contents in different commercial formulae 
studied are of special relevance. In this respect, the box plots are useful to compare the 
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different types of infant formula (Figure 1) and, simultaneously a non-parametric statistical 
analysis due to the short number of formulae (n < 12) in six of 9 studied groups, by means 
of Kruskall-Wallis test was carried out, establishing significant differences (p < 0.001). 
Therefore, it is possible to try to establish a relation of dependence based on chromium 
content in accordance with the type of infant formulae, the complexity of manufacturing 
process or even better, the predominant protein source used in infant formula manufacture. 
[Insert figure 1 about here] 
The higher chromium levels provided by hypoallergenic (18.16 ± 7.89 g l-1), lactose-free 
(11.37 ± 3.07 g l-1), preterm (11.48 ± 3.15 g l-1) and soya (10.43 ± 4.05 g l-1) formulae 
greatly exceed those values found in adapted (type 1: 6.29 ± 1.21 g l-1, functional 1: 7.77 
± 2.22 g l-1) formulae (U-Mann Whitney test; Type 1 – HA: p < 0.001, Type 1 – Preterm: 
p = 0.004, Type 1 – Lactose-free: p = 0.002, Type 1 – Soya, p = 0.007; Functional 1 – HA: 
p < 0.001, Functional 1 – Preterm: p = 0.040, Functional 1 – Lactose-free: p = 0.050). 
Follow-up (type 2: 8.73 ± 2.17 g l-1, functional 2: 8.35 ± 1.55 g l-1) and toddler (9.68 ± 
6.71 g l-1) formulae contain an intermediate level (U-Mann Whitney test; Type 2 – HA: p 
= 0.001; Functional 2 – HA: p = 0.001). 
Nowdays, manufacturers of infant formulae currently in use do not report any chromium 
content on the label, probably because no supplemental chromium is added or/and 
fortification practices is still exercised with caution by manufacturers of infant formulae. 
Thereby another factor should exists which explain the large variability of chromium 
observed in infant formulae. In this respect, our findings could clarify the sources or 
factors with special influence on chromium content in infant formulae. 
Firstly, the endogenous chromium content is contributed by raw material (cow’s milk or 
isolated soy protein). Generally, cow’s milk contains low and wide variable levels of 
chromium attributed to a different kind of feed consumed by these animals and to their 
different chromium content (Bratakos et al. 2002). In contrast, soy beans been 
characterized as a good source of chromium though its content is variable owing to soil 
composition and agricultural practices (Jorhem and Sundström 1993). Thereby, higher 
levels found in soya formulae could point out to the intrinsic chromium naturally present in 
soy protein. 
Following, it is known that chromium in valence state III, has a strong tendency to form 
coordinate and chelate compounds and interacts with protein molecules in order to make 
up strong and stable cross-links (Bratakos et al. 2002). Therefore, it is not surprising that 
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studied infant formulae provide a very different content according to the predominant 
protein source (milk fraction or main protein type) used in the manufacture. A statistical 
review of the data (Kruskall-Wallis test) in table V, establishes significant differences (p < 
0.001) in infant formulae analysed when are grouped focusing on the main protein. Apart 
from the formula based on free-aminoacids, the highest chromium content is founded in 
those formulae based on hydrolysed protein (whey hydrolysed: 13.03 ± 2.82 g l-1 and 
casein hydrolysed: 15.03 ± 5.52 g l-1); followed by a second group integrated by casein 
and soy based formulae with 11.37 ± 3.04 and 10.43 ± 4.05 g l-1, respectively; and, lastly, 
those formulae that include exclusively cow’s milk protein (whole-milk based: 9.12 ± 
8.54, skim-milk based: 8.20 ± 1.27 and whey based: 6.41 ± 1.08 g l-1), which degree of 
chromium enrichment is owing to the cow’s milk fraction. This fact is highlighted in the 
standard (adapted and follow-up) formulae, as can be observed in table VI (e.g. in type 2 
of follow-up formulae, whole-milk based: 12.85 ± 5.55; skim-milk based 7.74 ± 2.28 and 
whey based: 5.96 ± 2.24 g l-1). Undoubtedly, the intrinsic chromium is likely the most 
source of this element in the formulae with lower technical complexity of manufacture. 
[Insert tables V and VI about here] 
On the other hand, migration from equipment and fittings may explain the high chromium 
contents found in soya, lactose-free and preterm formulae. In addition, the highest levels of 
chromium in casein and whey hydrolysed formulae are a direct consequence of the 
aggressive protein hydrolysis treatment which involves the use of chemicals and additives. 
Moreover, other source of contamination must be considered in these formulae, the 
addition of several ingredients as calcium and phosphate salts, vitamins, other minerals 
and trace elements. 
Another potential source of chromium contamination to take account in infant formulae is 
the packaging in metal cans. The pasivation treatment in which chromium compounds is 
used to increase the lacquer adherence and resistance to oxidation of surface, can 
contribute significantly to the level of pick-up by canned infant formula (Reilly 2002, 
2004). Chromium levels for both powder and ready to use formulae are summarised in 
table VII. It was not possible to establish statistical differences (Wilcoxon’s test, p > 0.05) 
between the pairs of infant formula market in both aggregation form. However, powder 
formulae showed a tendency to be higher chromium content ha in ready to use formulae. 
Furthermore, general chromium levels in canned formula were consistently higher than 
those commercialised in aluminium bags (results not shown) for each types of infant 
formulae studied. 
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[Insert table VII about here] 
In conclusion, the chromium concentration of the studied infant formulae come from both 
origin endogenous and exogenous, although the relatively high levels found in preterm, 
soya and specialised formulae are most likely the result of leached from contact with 
stainless steel during manufacturing or packaging rather than fortification practices, given 
that chromium concentrations is not listed in none infant formula analysed being currently 
considered as a voluntary element for nutritional information labelling. 
 
Daily dietary chromium intake 
The daily intake of this element has been estimated using the chromium concentration 
mean value determined in the different types of formulae according to feeding tables and 
dose recommended by manufacturers, and taking into consideration the different stages of 
infancy (0-2 weeks: 600 mL, 3-4 weeks: 900 mL, 2 month: 1050 mL, 3 month: 1100 mL; 
4-5 month: 1250 mL, 6 month: 1000 mL, 7-12 months: 960 mL, 2 year: 560 mL, 3 year: 
560 mL), under the assumption that most infants observe similar feeding regimens and 
only formulae. Anyway, it is necessary to underline the fact that most of infants fed on 
follow-up formulae also receive beikost (complementary feeding) nutrients from four-five 
months old which may increase the chromium intake from other food sources better than 
formulae. 
The AI was set by the National Research Council based on chromium intake of infants 
principally fed on human milk, due to no functional criteria of chromium status reflect 
their dietary intake. These requirements have been established as 0.2 g day-1 (29 ng kg-
1day-1), 5.5 g day-1 (611 ng kg-1day-1), and 11 g day-1 (1222 ng kg-1day-1) for infants 0-6 
months, 7-12 months and 1-3 years old, respectively (FNB, 2001). 
The daily intake values calculated of chromium from the newborn period to the third year 
of life are show in table VIII. The chromium supplied by different infant formulae is 
clearly higher, approximately 45 and 75-100 times with standard and specialised 
(hypoallergenic and lactose-free) formulae respectively, than that provided by human milk. 
All studied formulae provided amounts of chromium intake higher than recommended AI. 
[Insert table VIII about here] 
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Unfortunately, the differences in bioavailability of chromium from breast milk and infant 
formulas are not known (Goldhaber 2003, FNB, 2001). However, chromium absorption via 
the gastrointestinal tract has been inversely related to dietary intake (Anderson and 
Kozlovsky 1985), depending upon chemical form, oxidation state and other factors (lack or 
presence of ascorbic acid, carbohydrates, phytate…) (Iyengar 1989). Chromium absorption 
is approximately 2 % at daily dietary intakes of 10 g, reaching 0.5 % when this is 
increased at least 40 g. Even though taking into account the percentage of absorption 
estimated, the studied formulae provide amounts close to the AI. 
Preterm infants are a special group of risk that may be susceptible to chromium deficiency. 
In this sense, the Canadian Paediatric Society (CPS 1995) has proposed a chromium 
requirement for low birth weight and premature infants (52-98 ng kg-1day-1) distinct from 
those for full-term infants. Figure 2 compares the daily chromium intake of infants fed on 
preterm formulae and human milk (Spanish and Reference range) with this recommended 
CPS-AI value. These formulae provide a chromium intake slightly greater than standard 
formulae and greatly exceeds, approximately 55 times, that supplied by both lower level 
human milk and recommended adequate intake. 
[Insert figure 2 about here] 
Finally, as mentioned above, several dietary components, different chemical components 
and trace elements deficiency state could influence chromium absorption in both sense 
enhancing or decreasing. Therefore, taking into account the markedly amount of chromium 
present in infant formulae analysed, it seems to be demanded to determine more 
definitively the safety of infant formulae. It is true that no data or reports have shown 
categorical adverse effects of chromium III in human nutrition, also it was suggested that 
tolerable limit for chromium is quite high with an extraordinary wide margin of safety. 
Thus, the Council for Responsible Nutrition (CRN) set its Upper Limit Safety (ULS) at 1 
mg day-1 (any form of Cr III) for adults (Hathcock 2004) based on a large number of trials 
and official reviews (FNB 2004, EVM 2003), that extrapolated to infants according to 
standard weight tables, reaches a maximum intake of 0.014 mg kg-1day-1 (0-2 weeks: 55 
mg day-1, 3-4 weeks: 63 mg day-1, 2 month: 76 mg day-1, 3 month: 87 mg day-1; 4-5 month: 
105 mg day-1, 6 month: 112 mg day-1, 7-12 months: 126 mg day-1, 2 year: 182 mg day-1, 3 
year: 224 mg day-1). 
Luckily, the maximum theoretical estimated intake of infant fed on studied formulae was 
lower than the ULS (figure 3). Standard (adapted and follow-up formulae) and toddler 
formulae contribute the lowest chromium intake (about 10 % ULS); soya, lactose-free and 
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preterm formulae gave an intermediate intake (15-18 % ULS) and hypoallergenic formulae 
provided the highest intake (26 % ULS). 
[Insert figure 3 about here] 
Thereby, taking into account the additional margin of safety established by upper limit, it 
seems appropriate to estimate the maximum chromium concentration in a hypothetical case 
of an infant formula to exceed the ULS. Following the recommended feeding of 
manufacturers, the limit of chromium in infant formula should range from 68 to 91 g l-1. 
Fortunately, none of infant formula studied reach so great level of chromium 
concentration. Nevertheless, it should be kept in mind that the level of this element as 
hexavalent chromium is unknown and, both, increased absorption of this chemistry form 
and low stomach acidity might represent a particular vulnerability situation for infants. Its 
quantification could be useful in the risk assessment (Soares 2000). 
 
Adventitious chromium contribution of drinking water 
Total chromium concentrations in drinking water are usually less than 2 g l-1, although 
levels as high as 120 g l-1 have been reported in several countries (WHO 2003). The 
WHO guidelines (WHO 1996) has considered the level of 50 g l-1, as a provisional 
guideline values, which is considered to be unlikely to give rise to significant risk to 
health. At this level, tap water appears to be an important source of chromium, 
contributing substantially to daily intake of infants. 
The chromium content found in drinking water samples collected in 88 representative 
sampling points from the Community of Navarra, was 0.74 ± 0.19 g l-1 (range 0.18 – 4.65 
g l-1). This median chromium value was used to calculate, based on feeding tbles for 
infant formula reconstitution, te complementary contribution from tap water to daily 
chromium intake of infants fed on powder infant formula. The theoretical chromium 
intake, including minimum and maximum values, is shown in table VIII. Comparatively, 
the influence of chromium level in drinking water on the final concentration of 
reconstituted powder infant formulae is limited. Nevertheless, it is representative that the 
supplied chromium by tap water might find by itself the AI during the first six months of 
life (approximately 2 - 4 times of the considered adequate intake) and at the same time, it 
match the amount provided by Spanish human milk in the feeding of preterm infants 
(figure 2). 
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Conclusions 
The findings of this survey demonstrate that chromium levels analysed in infant formula 
are markedly greater than those found in the reference range from human milk or those 
level (0.17 g l-1) calculated from the AI value to be necessarily provide by an infant 
formula to fulfil the recommendation. Therefore, the measurement of total chromium 
routinely by manufacturers and its inclusion in labelling information list will be of interest, 
especially in those complex infant formulae designed for special uses. In this respect, 
viewed from a research standpoint, speciation surveys (Bratter et al. 1998) are required in 
the future to research both, exogenous or intrinsic chromium source of origin and valence 
state of chromium released from stainless steel surfaces (Lameiras et al. 1998) with the 
objective of establish the total harmlessness and safety of infant formulae. 
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Table I. Chromium content (µg l-1) of mature human milk from different countries 
 
Country Reference Cr (µg L-1) n Range 
Austria Krachler et al. 2000 24.3 27 < 0.8 – 163 
Belgium Deelstra et al. 1988 0.14 ± 0.054 10 0.10 -0.23 
Finland Kumpulainen et al., 1983 0.39 ± 0.15 20 0.20 – 0.53 
Philippines WHO/IAEA 1989 3.46 10 0.97 – 6.13 
Germany Wappelhorst et al. 2002 10.8 19 3.1 – 19.4 
Guatemala WHO/IAEA 1989 1.17 9 0.34 – 2.52 
Hungary WHO/IAEA 1989 0.78 11 0.23 – 2.24 
Italy Aquilio et al. 1996 
Coni et al. 1990 
Muzzarelli et al. 1983 
1.2 ± 0.5 
9 
- 
110 
9 
8 
- 
2 -59 
0.5 -3.6 
Nigeria WHO/IAEA 1989 4.35 4 3.44 – 8.18 
Spain Cocho et al. 1992 
Rivero et al. 2001 
1.56 ± 0.78
0.8 ± 0.3* 
21 
1 
0.27 – 3.00 
- 
Sweden WHO/IAEA 1989 1.48 6 0.61 – 4.34 
United Kingdom MAFF 1996 - 4 < 16 - 40 
USA Casey and Hambidge 1984 0.27 ± 0.11 49 0.06 – 1.56 
 Anderson et al. 1993 0.18 ± 0.02 17 - 
 Mohamedshah et al. 1998 0.22 20 0.09-0.46 
Japan Gunshin et al. 1985 6.5 26 1.40 – 21.0 
Zaire WHO/IAEA 1989 1.07 11 < LOD – 3.99 
*deviation standard from five replicates 
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Table II. Graphite furnace program for the determination of chromium in infant formulae. 
 
Step Temperature (ºC) 
Ramp 
(s) 
Hold 
(s) 
Argon flow 
(ml min-1) Read on 
Drying 130 15 40 250 - 
Charring 1400 10 20 250 - 
Atomization 2300 0 5 0 Yes 
Cleaning 2500 1 5 250 - 
Cooling 20 - - 250 - 
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Table III. Chromium concentrations in different types of infant formulae investigated (µg l-
1). 
 
Infant formulae n Median Media ± SD* Range 
Adapted Formula 34 6.66 6.86 ± 1.09 2.62-16.15
Type 1 21 5.89 6.29 ± 1.21 2.62-14.09
Functional 1 13 6.75 7.77 ± 2.22 2.87-16.15
Follow-up Formula 30 8.05 8.60 ± 1.47 2.06-20.33
Type 2 20 8.24 8.73 ± 2.17 2.06-20.33
Functional 2 10 7.85 8.35 ± 1.55 5.96-13.10
Toddler Formula 6 8.12 9.68 ± 6.71 2.91-21.10
Preterm Formula 7 12.94 11.48 ± 3.15 4.83-14.61
Hypoallergenic F. 10 15.02 18.16 ± 7.89 8.22-46.50
Lactose-free F. 10 11.67 11.37 ± 3.07 5.29-18.28
Soya Formula 7 9.55 10.43 ± 4.05 5.82-19.15
Total 104 8.15 9.60 ± 1.13 2.06-46.50
*SD at 95 % interval 
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 Table IV. Chromium levels found from different types of infant formulae (µg l-1). 
 
Country Reference Cr (µg L-1) n Description 
Austria Krachler et al. 2000 < 4.0 – 14.5 4 Adapted formula 
Belgium Deelstra et al. 1988 6.2 ± 2.2 
12.1 
14.2 ± 7.3 
7 
1 
6 
Adapted formula 
Soy-based 
Special formula 
France Biego et al. 1998 45 ± 8 
26 ± 5 
5 
4 
Milk-based 
Soy-based 
Italy Muzzarelli et al. 1983 1.9 ± 1.8 
3.9 ± 0.6 
4.2 
7 
2 
1 
Adapted formula 
Lactose-free 
Soy-based 
Nigeria Ikem et al. 2002 6 ± 3 2 Powder Milk-based
Spain Cocho et al. 1992 
 
 
 
 
 
Viñas et al. 1997 
5.19 ± 3.26
3.83 ± 3.29
4.19 ± 1.42
13.92 ± 4.46
12.03 ± 7.58
21.12 ± 8.67
10.4* 
5.3* 
3.9* 
17 
7 
3 
3 
8 
9 
1 
1 
1 
Adapted formula 
Follow-up 
Preterm 
Soy-based 
Special formula 
Metabolic formula 
- 
- 
- 
United Kingdom Food Standards Agency 2003 
 
 
Ikem et al. 2002 
 
MAFF 1999 
 
MAFF 1996 
 
 
 
 
 
MAFF 1995 
8.9* 
10.8* 
40 
5 ± 5 
15 ± 4 
27.0 ± 6.7*
15.0 
< 16 – 20 
20 
< 16 – 20 
< 18 
20 – 30 
< 16 – 20 
2.16 – 99.22
18 
3 
3 
4 
6 
16 
4 
5 
5 
5 
5 
4 
4 
51 
Milk-based 
Soy-based 
Ready to use 
Powder milk-based 
Ready to use 
Powder milk-based 
Ready to use 
Powder Whey-bas. 
Liq. Whey-based 
Powder Casein-bas.
Liq. Casein-bas. 
Follow-up 
Soy-based 
Powder Milk-based
USA SHS 2005 
Ikem et al. 2002 
11.2* 
7 ± 9 
11 ± 7 
- 
3 
2 
Free aa 
Powder Milk-based 
Powder Soy-based 
 Patterson et al. 1985 7.5 
18 
1 
1 
Preterm formula 
Preterm formula 
5 
 Deelstra et al. 1988 3.3 – 19.6 
12.1 
5.7 
7.5-8.1 
18.0-23.4 
11 
1 
1 
2 
3 
Milk-based 
Soy-based 
Lactose-free 
HA 
Therapeutic F. 
 Abbot 1998 7.7 
20 – 40 
142 – 174 
8 – 22 
- 
- 
- 
- 
Milk-based 
Soy-based 
Casein Hydrol. F. 
Preterm 
*Recalculated chromium concentration and expressed in µg/L 
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Table V. Chromium content in infant formulae according to the main protein contained (µg l-
1). 
 
Infant formula n Median Media ± SD Range 
Whey-based 23 6.66 6.41 ± 1.08 a 2.62-13.53 
Skim-milk-based 41 7.54 8.20 ± 1.27 a, b 2.06-21.10 
Whole-milk-based 4 7.25 9.12 ± 8.54 a, b, c 5.21-16.77 
Soy-based 7 9.55 10.43 ± 4.05  b, c, d 5.82-19.15 
Casein-based 10 11.67 11.37 ± 3.04  c, d, e 5.29-18.28 
Whey hydrolysed 13 12.16 13.03 ± 2.82 c, d, e 7.03-20.68 
Casein hydrolysed 5 14.08 15.03 ± 5.52 e 9.74-22.01 
Free aminoacids 1 - 46.50 f - 
a, b, c, d, e, f Results with the same superscript letter were not significantly different (p > 0.05)  
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Table VI. Chromium content in infant formulae according to the different types and main 
protein contained (µg l-1). 
 
Infant formulae n Median Media ± SD Range 
Adapted Formula     
Type 1     
Whole-milk-based 1 - 5.21 - 
Skim-milk-based 5 5.23 5.86 ± 1.94 4.75-8.54 
Whey-based 12 5.98 5.53 ± 1.29 2.62-8.65 
Whey hydrolysed 3 10.18 10.43 ± 6.50 7.03-14.09 
Functional 1     
Whole-milk-based 1 - 5.58 - 
Skim-milk-based 7 6.66 8.48 ± 4.07 4.10-16.15 
Whey-based 4 7.02 6.22 ± 3.64 2.87-7.97 
Whey hydrolysed 1 - 11.22 - 
Follow-up Formula     
Type 2     
Whole-milk-based 2 12.85 12.85 ± 5.55* 8.92-16.77 
Skim-milk-based 13 808 7.74 ± 2.28 2.06-14.55 
Whey-based 3 6.41 5.96 ± 2.24 4.92-6.54 
Whey hydrolysed 2 15.20 15.20 ± 7.26* 10.06-20.33 
Functional 2     
Skim-milk-based 7 8.02 8.39 ± 2.37 5.96-13.10 
Whey-based 3 7.67 8.26 ± 3.08 7.43-9.69 
Toddler Formula     
Skim-milk-based 6 8.12 9.68 ± 6.71 2.91-21.10 
Preterm Formula     
Skim-milk-based 3 10.87 10.10 ± 4.93* 4.83-14.61 
Whey-based 1 - 13.53 - 
Casein hydrolysed 2 11.81 11.81 ± 2.92* 9.74-13.87 
Whey hydrolysed 1 - 12.94 - 
Hipoallergenic Formula     
Casein hydrolysed 3 15.47 17.19 ± 4.23* 14.08-22.01 
Whey hydrolysed 6 13.36 13.92 ± 5.67 8.22-20.68 
Free aminoacids 1 - 46.50 - 
Lactose-free F.     
Casein-based 10 11.67 11.37 ± 3.07 5.29-18.28 
Soya Formula     
Soy-based 7 9.55 10.43 ± 4.05 5.82-19.15 
* Standard deviation value 
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Table VII. Chromium levels (µg l-1) from different container types of powder or liquid 
formulae. 
 
 n Median Media± SD Range 
Powder F. 97 8.22 9.83 ± 1.19 2.06-46.50 
Canned F. 61 8.39 10.00 ± 1.69 2.06-46.50 
Al. bag F. 36 7.82 9.55 ± 1.56 2.87-22.01 
Ready-to-use 7 7.43 6.35 ± 2.90 2.70-10.87 
Tetra brick 4 5.82 6.30 ± 5.78 2.70-10.87 
Glass bottle 2 8.18 8.18 ± 1.05* 7.44-8.92 
Plastic bottle 1 - 2.91 - 
* Standard deviation value 
 
 
 
 
9 
Table VIII. Daily intakes of chromium for infants fed on infant formulae and drinking 
water used in the reconstitution of powder formulae (µg day-1). 
 
Age Adapted Follow-up Toddler Lactose-free 
HA Soya Drinking 
water 
0 - 2 weeks 4.1 ± 0.7   6.8 ± 1.8 10.9 ± 4.7 6.3 ± 2.4 0.40 ± 0.10
3 - 4 weeks 6.2 ± 1.0   10.3 ± 2.8 16.3 ± 7.1 9.4 ± 3.6 0.53 ± 0.14
2 month 7.2 ± 1.1   11.9 ± 3.2 19.1 ± 8.3 11.0 ± 4.3 0.62 ± 0.16
3 month 7.5 ± 1.2   12.5 ± 3.4 20.0 ± 8.7 11.5 ± 4.5 0.67 ±0.17
4 - 5 months 8.6 ± 1.4 10.8 ± 1.8  14.2 ± 3.9 22.7 ± 9.9 13.0 ± 5.1 0.78 ± 0.20
6 month 6.9 ± 1.1 8.6 ± 1.5  11.4 ± 3.1 18.2 ± 7.9 10.4 ± 4.0 0.78 ± 0.20
7 - 12 months  8.3 ± 1.4 9.3 ± 6.4    0.60 ± 0.15
2 year   5.4 ± 3.8    0.36 ± 0.09
3 year   5.4 ± 3.8    0.36 ±0.09
 
 
 
 
Follow-up Functional 2
Adapted Functional 1
Soya
Lactose-free
Hypoallergenic
Preterm
Toddler
Follow-up Type 1
Adapted Type 1
Cr (g/L) 30.0
25.0
20.0
15.0
10.0
5.0
0
Soya
Skim b.
Skim b.
Skim b.
Whey H.
Whey H.
Free aa
(46.50)
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Figure 1. Box plots of determined chromium content in different types of infant formulae 
studied (µg l-1) 
Figure 2. Daily dietary chromium intake (µg day-1) for infant fed on premature infant 
formulae, human milk (Spanish and Reference levels) and drinking water used in powder 
formula reconstitution. 
Figure 3. Percentages of Upper Limit Safety for chromium estimated from infant 
formulae. 
 
